Aaron J. Fowler

Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia.

LKB1 inactivation sensitizes non-small cell lung cancer to pharmacological aggravation of ER stress.